G. Omura

发表

Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol.

L. Einhorn, F. Greco, P. Loehrer, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ICON2: randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer

M. Buyse, E. Dreher, Torri, 1998, The Lancet.

Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Etoposide (CHOPE) for Advanced-Stage Hodgkin's Disease: CALGB 8856

G. Petroni, F. Millard, B. Peterson, 2001, Cancer investigation.

Progress in gynecologic cancer research: the Gynecologic Oncology Group experience.

G. Omura, 2008, Seminars in oncology.

A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study.

C. Mangan, R. Park, S. Lifshitz, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Modified Fibonacci search.

G. Omura, George A Omura, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase 1 Dose-Finding Trials and Fibonacci

G. Omura, 2006, Clinical Cancer Research.

Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: a Gynecologic Oncology Group Study.

B. Monk, C. Tian, D. Moore, 2010, Gynecologic oncology.

A randomized trial of cyclophosphamide, doxorubicin, and cisplatin with or without bacillus Calmette-Guerin in patients with suboptimal stage III and IV ovarian cancer: a Gynecologic Oncology Group study.

P. Disaia, E. Yordan, M. Brady, 1990, Gynecologic oncology.

Advances in the Treatment of Gynecologic Malignancies

R. Alvarez, G. Omura, R. Kim, 2002 .

Chemotherapy for cervix cancer.

G. Omura, 1994, Seminars in oncology.

National Institutes of Health Consensus Development Conference Statement on Cervical Cancer

W. H. Hall, P. Grigsby, B. Kramer, 1997 .

A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A gynecologic oncology group study

E. Yordan, W. Creasman, H. Homesley, 1986, Cancer.

Phase III trial of paclitaxel at two dose levels, the higher dose accompanied by filgrastim at two dose levels in platinum-pretreated epithelial ovarian cancer: an intergroup study.

S. Arbuck, H. Averette, S. Wadler, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Using the expected survival to explain differences between the results of randomized trials: a case in advanced ovarian cancer.

M. Buyse, M. Parmar, V. Torri, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I study of paclitaxel, doxorubicin, and cisplatin in patients with previously untreated epithelial ovarian cancer.

E. Partridge, R. Alvarez, R. Naumann, 1998, Gynecologic oncology.

Phase 2 trial of moderately high dose single agent mitoxantrone in platinum and paclitaxel-refractory ovarian cancer.

S. Lichtman, H. Homesley, G. Omura, 1998, Gynecologic oncology.

Dose‐escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma

G. Petroni, B. Parker, N. Bartlett, 2001, Cancer.

Primary chemotherapy of epithelial ovarian carcinoma.

G. Omura, B. Siller, 1994, Seminars in surgical oncology.

A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma.

C. Elmets, T. Kuzel, E. Olsen, 2001, Journal of the American Academy of Dermatology.

Pharmacokinetics and Pharmacodynamics of Peldesine (BCX‐34), a Purine Nucleoside Phosphorylase Inhibitor, following Single and Multiple Oral Doses in Healthy Volunteers

G. Omura, J. Kisicki, T. Viegas, 2000, Journal of clinical pharmacology.

Randomized comparison of two combination regimens versus minimal chemotherapy in nonsmall-cell lung cancer: a Southeastern Cancer Study Group Trial.

L. Einhorn, A. Bartolucci, F. Greco, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III comparison of cisplatin alone versus cisplatin, doxorubicin and cyclophosphamide in the treatment of bladder (urothelial) cancer: a Southeastern Cancer Study Group trial.

M. Troner, R. Birch, G. Omura, 1987, The Journal of urology.

Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study.

D. Mutch, D. Clarke‐Pearson, J. Blessing, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II randomized study of doxorubicin, vincristine, and 5-FU versus cyclophosphamide in advanced squamous cell carcinoma of the cervix.

R. Birch, G. Omura, E. Vélez‐garcía, 1981, Cancer treatment reports.

Chemotherapy of gynecologic cancer with nitrosoureas: a randomized trial of CCNU and methyl-CCNU in cancers of the cervix, corpus, vagina, and vulva.

H. Shingleton, W. Creasman, J. Blessing, 1978, Cancer treatment reports.

Re: Mucinous ovarian cancer.

G. Omura, 2005, Gynecologic oncology.

Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study.

E. Yordan, R. Kurman, M. Brady, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Stage III ovarian tumors of low malignant potential treated with cisplatin combination therapy (a Gynecologic Oncology Group study).

E. Yordan, G. Sutton, B. Bundy, 1991, Gynecologic oncology.

Ifosfamide plus doxorubicin in metastatic adult sarcomas: a multi-institutional phase II trial.

J. Hainsworth, G. Sledge, P. Loehrer, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Re: early stage high-risk ovarian cancer.

G. Omura, 2007, Gynecologic oncology.

Treatment of Gynecologic Sarcomas

G. Omura, 1988 .

Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma.

N. Hornback, G. Omura, F. Major, 1986, International journal of radiation oncology, biology, physics.

Chemotherapy of cervix cancer with doxorubicin and cisplatin: A phase I pilot study of the Gynecologic Oncology Group

K. Hatch, G. Omura, J. Hubbard, 1985, American Journal of Clinical Oncology.

Combination therapy of solid tumors using 1,3‐bis(2‐chloroethyl)‐l‐nitrosourea (BCNU), vincristine, methotrexate, and 5‐fluorouracil

G. Omura, Gayle A. Roberts, 1973, Cancer.

A randomized comparison of high-dose versus conventional-dose cyclophosphamide, doxorubicin, and vincristine for extensive-stage small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group.

C. Perez, L. Einhorn, R. Vollmer, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bone marrow examination in small cell lung cancer.

G. Omura, 1987, Annals of internal medicine.

Sequentially administered 5-azacitidine and amsacrine in refractory adult acute leukemia: a phase I-II trial of the Southeastern Cancer Study Group.

C. Presant, G. Omura, E. Winton, 1985, Cancer treatment reports.

A phase III trial of high-dose cytosine arabinoside with or without etoposide in relapsed and refractory acute myelogenous leukemia. A Southeastern Cancer Study Group trial.

A. Bartolucci, M. Stagg, J. Moore, 1994, Leukemia.

Medical oncology in the 1990s

J. Tobias, G. Omura, J. Sher, 1991, The Lancet.

Inhibitors of the enzyme purine nucleoside phosphorylase as potential therapy for psoriasis.

G. Omura, P. Morris, 2000, Current pharmaceutical design.

Age as a prognostic factor in ovarian carcinoma: The gynecologic oncology group experience

M. Brady, W. Creasman, S. Williams, 2010, Cancer.

Meta-analysis of cisplatin, doxorubicin, and cyclophosphamide versus cisplatin and cyclophosphamide chemotherapy of ovarian carcinoma.

M. Brady, G. Omura, 1993, Obstetrics and gynecology.

Phase II evaluation of cisplatin in advanced hepatocellular carcinoma and cholangiocarcinoma: a Southeastern Cancer Study Group Trial.

B. Kramer, L. Einhorn, A. Bartolucci, 1986, Cancer treatment reports.

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B.

R. Mayer, C. Schiffer, J. Moore, 1994, The New England journal of medicine.

Randomized Phase II Evaluation of Iproplatin (CHIP) and Carboplatin (CBDCA) in Lung Cancer: A Southeastern Cancer Study Group Trial

B. Kramer, R. Birch, P. Desimone, 1988, American journal of clinical oncology.

A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study.

A. Bartolucci, R. Weiner, G. Omura, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical pharmacology of cytarabine in patients with acute myeloid leukemia: a Cancer and Leukemia Group B study

C. Bloomfield, G. Rosner, R. Schilsky, 1995, Cancer Chemotherapy and Pharmacology.

A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas

R. Zaino, J. Thigpen, T. Sedlacek, 1983, Cancer.

Human immunodeficiency virus-associated skin lesions.

G. Omura, E. Omura, 1989, JAMA.

Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study.

J. Berek, B. Bundy, G. Omura, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study.

J. Thigpen, B. Bundy, W. Hoskins, 1992, Gynecologic oncology.

Bone marrow biopsy.

G. Omura, 1981, American Journal of Surgical Pathology.

Phase III study of BCOP v CHOP in unfavorable categories of malignant lymphoma: a Southeastern Cancer Study Group trial.

H. Silberman, A. Bartolucci, G. Omura, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience.

E. Yordan, M. Brady, R. Park, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group.

Mike Clarke, K Wheatley, A Riccardi, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized phase III comparison of three doxorubicin-based chemotherapy regimens in advanced non-small cell lung cancer: a Southeastern Cancer Study Group trial.

R. Oldham, R. Birch, S. Krauss, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Late intensification therapy in adult acute lymphoid leukemia: long-term follow-up of the Southeastern Cancer Study Group experience.

D. S. Gordon, A. Bartolucci, G. Omura, 1994, Leukemia & lymphoma.

Long-term survival in adult acute lymphoblastic leukemia: follow-up of a Southeastern Cancer Study Group trial.

G. Omura, M. Raney, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin, and vincristine in limited small-cell lung cancer.

J. Crawford, D. Johnson, F. Greco, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ondansetron (GR 38032F): A Novel Antiemetic Effective in Patients Receiving a Multiple‐Day Regimen of Cisplatin Chemotherapy

J. Hainsworth, A. Finn, G. Omura, 1991, American journal of clinical oncology.

Chemotherapy for stage IVB or recurrent cancer of the uterine cervix.

G. Omura, 1996, Journal of the National Cancer Institute. Monographs.

Phase II study of hexamethylmelamine in refractory Hodgkin's disease, other lymphomas, and chronic lymphocytic leukemia.

R. Birch, G. Omura, G. Broun, 1981, Cancer treatment reports.

Phase II Study of beta-2'-deoxythioguanosine in adult acute leukemia.

Y. Ahn, G. Faguet, R. Smalley, 1977, Cancer treatment reports.

IMP: and AMP pyrophosphate Phosphoribosyltransferase in Leukemic and Normal Human Leukocytes 1

G. Omura, M. Baliś, John L. Smith, 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Current status of chemotherapy for cancer of the cervix.

G. Omura, 1992, Oncology.

Treatment of refractory adult acute leukemia with 5-azacytidine plus beta-2'-deoxythioguanosine.

A. Bartolucci, G. Omura, W. Vogler, 1979, Cancer treatment reports.

Combination therapy with 5-azacytidine plus beta-2'-deoxythioguanosine in adult acute leukemia.

G. Omura, 1977, Cancer treatment reports.

Treatment of acute myelogenous leukemia: Influence of three induction regimens and maintenance with chemotherapy or BCG immunotherapy

J. Lefante, G. Omura, W. Knospe, 1982, Cancer.

A randomized, double-blind comparison of single-dose and divided multiple-dose dolasetron for cisplatin-induced emesis

J. Hainsworth, G. Omura, K. Ryan, 1996, Cancer Chemotherapy and Pharmacology.

Randomized trial of radiotherapy to the thorax in limited small-cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: a preliminary report.

H. Cohen, C. Perez, L. Einhorn, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized clinical trial of remission induction, consolidation, and chemo-immunotherapy maintenance in adult acute myeloblastic leukemia

Writing group, A. Bartolucci, R. Smalley, 1978, Cancer Immunology, Immunotherapy.

Coexistence of paroxysmal nocturnal hemoglobinuria and chronic lymphocytic leukemia

G. Omura, 1981, American journal of hematology.

Alternating sequential combination chemotherapy in the management of advanced Hodgkin's disease: A southeastern cancer study group trial

A. Bartolucci, R. Gams, G. Omura, 1986, Cancer.

Prognosis in adult acute myelogenous leukemia related to performance status and other factors

S. Soong, G. Omura, Vinod Kansal, 1976, Cancer.

Clinical pharmacology of oral intermediate-dose methotrexate with or without probenecid

M. Lilly, G. Omura, 2004, Cancer Chemotherapy and Pharmacology.

Treatment of chronic lymphocytic leukemia using chlorambucil and prednisone with or without cycle‐active consolidation chemotherapy .A southeastern cancer study group trial

A. Bartolucci, G. Omura, W. Knospe, 1986, Cancer.

Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: a randomized trial of the Southeastern Cancer Study Group.

A. Bartolucci, J. Crawford, D. Johnson, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Darier, Pautrier, and the "microabscesses" of mycosis fungoides.

G. Omura, 2002, Journal of the American Academy of Dermatology.

Using t he E xpected S urvival t o E xplain D ifferences Between t he R esults o f R andomized T rials: A C ase i n A dvanced O varian C ancer

M. Buyse, M. Parmar, V. Torri, 2003 .

Long-term follow-up of a randomized post-induction therapy trial in acute myelogenous leukemia (a Southeastern Cancer Study Group trial).

A. Bartolucci, M. Stagg, J. Moore, 1995, Leukemia.

A phase-three trial comparing daunorubicin or idarubicin combined with cytosine arabinoside in acute myelogenous leukemia.

G. Omura, W. Vogler, E. Vélez‐garcía, 1989, Seminars in oncology.

Patterns of failure in combined chemotherapy and radiotherapy for limited small cell lung cancer: Southeastern Cancer Study Group experience.

C. Perez, F. Greco, R. Birch, 1988, NCI monographs : a publication of the National Cancer Institute.

Phase II evaluation of doxorubicin plus bleomycin in hepatocellular carcinoma: a Southeastern Cancer Study Group trial.

A. Bartolucci, G. Omura, M. Ravry, 1984, Cancer treatment reports.

Case Report: Mycosis Fungoides: Carcinogens and Cerebral Involvement

G. Omura, M. Conrad, 1987 .

Hexamethylmelamine in mustard-resistant ovarian adenocarcinoma.

F. Greco, R. Birch, G. Omura, 1981, Cancer treatment reports.

Clinical pharmacology of intermediate-dose oral methotrexate

F. Ostroy, G. Omura, D. Smith, 2004, Cancer Chemotherapy and Pharmacology.

Etoposide (VP-16) and cisplatin at maximum tolerated dose in non-small cell lung carcinoma: a Cancer and Leukemia Group B study.

J. Herndon, C. Cirrincione, M. Green, 1995, Lung cancer.

Phase II evaluation of cisplatin in squamous carcinoma of the esophagus: a Southeastern Cancer Study Group trial.

A. Bartolucci, G. Omura, M. Ravry, 1985, Cancer treatment reports.

A RANDOMIZED TRIAL OF CISPLATIN VERSUS CISPLATIN+ MITOLACTOL VERSUS CISPLATIN + ISOFOSPHAMIDE IN ADVANCED SQUAMOUS CARCINOMA OF THE CERVIX BY THE GYNECOLOGIC ONCOLOGIC GROUP

J. Blessing, G. Omura, L. Vaccaiello, 1996 .

A randomized comparison of melphalan versus melphalan plus hexamethylmelamine versus adriamycin plus cyclophosphamide in ovarian carcinoma

J. Blessing, G. Omura, L. Leone, 1983, Cancer.

Synchronization with phase-specific agents in leukemia and correlation with clinical response to chemotherapy.

G. Omura, W. Knospe, W. Vogler, 1976, Cancer treatment reports.

Phase II study of amsacrine gluconate in refractory leukemia.

Antonio J. Grillo-López, K. Zuckerman, G. Omura, 1983, Cancer treatment reports.

Combination chemotherapy with cyclophosphamide, adriamycin, intermediate dose methotrexate, and folinic acid rescue (CAMF) in advanced lung cancer

A. Bartolucci, G. Omura, F. Robert, 1980, Cancer.

Are all stage III cancers of the ovary really cancers of the ovary?

G. Omura, 1981, Cancer Clinical Trials.

Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer.

C. Perez, L. Einhorn, A. Bartolucci, 1990, Annals of internal medicine.

Prognostic Factor Analysis of Central Nervous System Relapse in Adult Acute Lymphoblastic Leukemia: A Southeastern Cancer Study Group Report

G. Omura, D. Bass, 1994, American journal of clinical oncology.

Value of radiation therapy to the thorax in limited small cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation

H. Cohen, C. Perez, L. Einhorn, 1984 .

Phase II evaluation of maytansine (NSC 153858) in advanced cancer: A Southeastern Cancer Study Group trial

R. Birch, G. Omura, M. Ravry, 1985, American journal of clinical oncology.

Intensified Post-Remission Chemotherapy for Adults with Acute Myeloid Leukemia: An Update of CALGB 8525

Roger B. Davis, R. Mayer, C. Schiffer, 1997 .

Flynn et al.: does the interval from primary surgery to chemotherapy influence progression-free survival in ovarian cancer?

G. Omura, 2003, Gynecologic oncology.